Investigational OCTA Devices Show Promise in Diabetic Disease Assessment - Quiz - MDSpire

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.

  • By

  • Patricio G. Schlottmann, MD

  • Patricio G. Schlottmann, MD

  • May 14, 2026

  • 2 min

Share

Original Source(s)

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

  • by Patricio G. Schlottmann, MD, Patricio G. Schlottmann, MD

  • May 14, 2026

Related Content

Metformin’s Potential Role in Posterior Capsule Opacification

Common diabetes therapy reaches intraocular lens tissue and may help limit PCO, says newly published data

  • March 30, 2026

  • 3 min
Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

Comparative study of the therapeutic effects of different medications on DM-associated dry eye syndrome after vitrectomy